Masataka Taguchi

Years Active: 2020-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuhito Nannya, Magnus Tobiasson, Shinya Sato, Elsa Bernard, Shigeki Ohtake, June Takeda, Maria Creignou, Lanying Zhao, Manabu Kusakabe, Yuhei Shibata, Nobuhiko Nakamura, Mizuki Watanabe, Nobuhiro Hiramoto, Yusuke Shiozawa, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Yoshida, Nobuyuki Kakiuchi, Hideki Makishima, Masahiro Marshall Nakagawa, Kensuke Usuki, Mitsumasa Watanabe, Kazunori Imada, Hiroshi Handa, Masataka Taguchi, Toru Kiguchi, Kazuma Ohyashiki, Takayuki Ishikawa, Akifumi Takaori-Kondo, Hisashi Tsurumi, Senji Kasahara, Shigeru Chiba, Tomoki Naoe, Satoru Miyano, Elli Papaemmanuil, Yasushi Miyazaki, Eva Hellström Lindberg, Seishi Ogawa
Post-azacitidine clone size predicts outcome of patients with myelodysplastic syndromes and related myeloid neoplasms. Blood advances (2023)
Eo Toriyama, Tomoko Hata, Ken-Ichi Yokota, Masahiko Chiwata, Rena Kamijo, Miki Hashimoto, Masataka Taguchi, Makiko Horai, Masatoshi Matsuo, Emi Matsuo, Yumi Takasaki, Yasuhisa Kawaguchi, Hidehiro Itonaga, Shinya Sato, Koji Ando, Yasushi Sawayama, Jun Taguchi, Yoshitaka Imaizumi, Hideki Tsushima, Tatsuro Jo, Shinichiro Yoshida, Yukiyoshi Moriuchi, Yasushi Miyazaki
No clear survival benefit of azacitidine for lower-risk myelodysplastic syndromes: A retrospective study of Nagasaki. Cancer science 111 (12) (2020)

Masataka Taguchi.css-eqlu8i{font-size:small;padding-left:4px;}